ASP Isotopes (ASPI) Operating Expenses (2022 - 2026)

ASP Isotopes' Operating Expenses history runs 5 years deep, the most recent figure standing at $26.6 million for Q1 2026.

• On a quarterly basis, Operating Expenses rose 220.74% year-over-year to $26.6 million in Q1 2026; TTM through Mar 2026 was $81.6 million, a 170.71% increase from a year earlier, with the FY2025 full-year figure at $63.3 million, up 126.5% from the prior year.
• Operating Expenses eased to $26.6 million in Q1 2026 per ASPI's latest filing, from $27.1 million in the prior quarter.
• Across five years, Operating Expenses topped out at $27.1 million in Q4 2025 and bottomed at $827959.0 in Q2 2022.
• The 5-year median for Operating Expenses is $5.7 million (2024), against an average of $8.2 million.
• Across the five-year window, Operating Expenses jumped 425.09% in 2023 and surged 35.86% in 2025, its largest moves.
• Year by year, Operating Expenses stood at $1.5 million in 2022, then soared by 185.26% to $4.2 million in 2023, then jumped by 98.3% to $8.3 million in 2024, then soared by 228.39% to $27.1 million in 2025, then retreated by 2.03% to $26.6 million in 2026.
• Per Business Quant, the three latest ASPI Operating Expenses figures stand at $26.6 million (Q1 2026), $27.1 million (Q4 2025), and $15.4 million (Q3 2025).